������Ƶ

Researchers in the lab of Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research, have added BI-0474 as the second molecule co-discovered by Vanderbilt to the open science portal opnMe.com, an initiative being driven by biopharmaceutical company Boehringer Ingelheim.

Graduate student Hillary Layden studies transcriptional control of cancer in the lab of Scott Hiebert, Hortense B. Ingram Chair in Cancer Research and professor of biochemistry. She shares the results from her research in which she used a deep genomic analysis to determine how protein mutations influence gene expression to promote cancer progression.

Three Vanderbilt University School of Nursing faculty members won awards at the American College of Nurse Midwives annual awards celebration in May 2024.

Sean Seymore, Centennial Professor of Law at Vanderbilt Law School, argues that federal courts have “abandoned their gatekeeping function” for protecting public health in patent cases.

A Vanderbilt scientific team has succeeded in adjusting the daily biological clock of cyanobacteria, making the blue-green algae a more prolific producer of renewable fuels, chemicals, and pharmaceuticals, like insulin.

A Tri-Institutional Seminar series has been initiated by the School of Medicine Basic Sciences, Meharry Medical College and Fisk University, focused on trainee development and promoting collaboration and existing ties between scientists affiliated with all three institutions. The series is open to the public.

Leading global health care knowledge provider BMJ has signed a new read-and-publish agreement with the Jean and Alexander Heard Libraries at Vanderbilt University. The agreement allows Vanderbilt-affiliated corresponding authors to publish their primary research open access without incurring article processing charges.

With hundreds of thousands of people in the United States having a stroke annually, Vanderbilt researchers are developing technology that could revolutionize the way blood clots are removed by allowing surgeons to complete the process more efficiently and safely.

Ken Lau, professor of cell and developmental biology, and colleagues have laid out the principles governing the biology of early, precancerous lesions, which are different from the principles that govern cancers. Their authoritative perspective was published in Cancer Discovery in April 2024.

Clintoria Williams, associate professor in the Department of Neuroscience, Cell Biology and Physiology at Wright State University, has received the John F. Perkins, Jr. Research Career Enhancement Award from the American Physiological Society. This will enable her to join Vanderbilt as a visiting scholar in the Department of Molecular Physiology and Biophysics for four months to collaborate more closely with Antentor Hinton Jr., assistant professor in the department.

David Cortez, a world-renowned leader in DNA damage response and repair mechanisms and the pathophysiology of cancer, developed and applied highly creative technological approaches to identify and characterize proteins involved in DNA and genome maintenance. The Protein Society is the premier international society dedicated to supporting protein research.

In support of its commitment to fighting health inequities, Vanderbilt University School of Nursing has launched an ambitious campaign to raise and match $1 million to support health disparity research. Dean Pamela Jeffries recently announced the school’s Nursing Health Equity Fellowship program, setting aside $1 million for health equity research at the school and asking VUSN supporters to make a 1:1 philanthropic match to fund this critical research. Read More

Three Vanderbilt School of Nursing faculty members were recently recognized for excellence across various nursing disciplines with fellow designations and major awards.

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years.

The Vanderbilt Memory and Alzheimer's Center hosted its fifth Annual Vanderbilt Alzheimer’s Disease Research Day on April 10 with the theme of “big data.” Aside from presentations from faculty from across campus and the School of Medicine Basic Sciences, the day featured data blitzes, a keynote presentation, and a poster reception with more than 45 posters.

Incoming assistant professor of pharmacology Quynh Anh Nguyen spearheaded research that points to a previously unidentified region of the hippocampus as responsible for epileptic seizures. The work could lead to new avenues of treatment to help epilepsy patients control their seizures.

The lab of Tina Iverson, Louise B. McGavock Professor and professor of pharmacology, in collaboration with researchers at the University of California, San Francisco; Stanford University; and The Weizmann Institute of Science in Israel have published new work in Nature Microbiology, providing new insights on chemotaxis.

Molecular biologist Emily Hodges, assistant professor of biochemistry, studies the regulatory elements of our genome and is interested in parsing how changes in DNA sequence affect gene regulation.

Jennifer Pietenpol, Ingram Professor of Cancer Research and professor of biochemistry, is the 2024 recipient of the Science of Oncology Award, which is presented annually to an individual who has made outstanding contributions to basic or translational research in cancer.

The researchers, including Vanderbilt’s team led by Kari Hoffman, focused their efforts on the detection of hippocampal ripples, which are considered biomarkers of memory and are affected by epilepsy and Alzheimer’s disease. Read More